NCT03136887 - JOURNEY II XR Safety and Effectiveness PMCF | Biotech Hunter

Enrollment

176

Participants

Timeline

Start Date

July 28, 2017

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2029

Conditions

Rheumatoid Vasculitis With Rheumatoid Arthritis of KneeUnilateral Post-Traumatic Osteoarthritis of KneeKnee OsteoarthritisDegenerative Arthritis Peripheral JointFailed OsteotomiesFailed Unicompartmental Replacement

Interventions

DEVICE

JOURNEY II XR Total Knee System

Trial Locations (14)

10003

NYU Hospital for Joint Diseases / NYU Langone Medical Center, New York

10021

Hospital for Special Surgery, New York

10032

Columbia University Center for Hip & Knee Replacement, New York

21401

Anne Arundel Medical Center, Annapolis

33334

Holy Cross Orthopedic Institute, Fort Lauderdale

45219

The Lindner Research Center at the Christ Hospital, Cincinnati

48307

DeClaire LaMacchia Orthopaedic Institute, Rochester

60504

Castle Orthopaedics & Sports Medicine, S.C., Aurora

60612

Midwest Orthopaedics at Rush, Chicago

89503

Reno Orthopaedic Center, Reno

92354

Loma Linda University Dept. of Orthopaedic Surgery, Loma Linda

97239

Oregon Health & Science University, Portland

98201

Providence Regional Medical Center Everett, Everett

08691

Mercer Bucks Orthopaedics, Hamilton

All Listed Sponsors

lead

Smith & Nephew, Inc.

INDUSTRY